Sanara MedTech (SMTI) Cash from Financing Activities (2010 - 2026)
Sanara MedTech (SMTI) posted Cash from Financing Activities of -$475219.0 for Q1 2026, down 440.84% on a QoQ basis from $139427.0 in Q4 2025, and down 103.96% year-over-year from $12.0 million in Q1 2025.
Sanara MedTech (SMTI) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Sanara MedTech's Cash from Financing Activities history runs 15 years deep, the most recent figure standing at -$475219.0 for Q1 2026.
- Quarterly Cash from Financing Activities fell 103.96% year-over-year to -$475219.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 111.91% YoY) and the FY2025 annual result came in at $8.9 million, down 48.82% from the prior year.
- Cash from Financing Activities was -$475219.0 for Q1 2026 at Sanara MedTech, down from $139427.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $14.4 million in Q3 2024 and bottomed at -$2.5 million in Q2 2025.
- A 5-year average of $2.2 million and a median of -$144409.5 in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities slumped 787.6% — and 2025, when it soared 1919.73%.
- Sanara MedTech's Cash from Financing Activities stood at -$304415.0 in 2022, then surged by 38.94% to -$185888.0 in 2023, then slumped by 546.06% to -$1.2 million in 2024, then surged by 111.61% to $139427.0 in 2025, then slumped by 440.84% to -$475219.0 in 2026.
- Business Quant data shows SMTI's Cash from Financing Activities at -$475219.0 in Q1 2026, $139427.0 in Q4 2025, and -$774749.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Sanara MedTech | 233.71 Mn | 220.11 Mn | 25.87 Mn | -475,219.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -475,219.00 |
| Mar 31, 2026 | -475,219.00 |
| Dec 31, 2025 | 139,427.00 |
| Dec 31, 2025 | 139,427.00 |
| Sep 30, 2025 | -774,749.00 |
| Sep 30, 2025 | -774,749.00 |
| Jun 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | -2.47 Mn |
| Mar 31, 2025 | 11.99 Mn |
| Mar 31, 2025 | 11.99 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | 14.43 Mn |
| Sep 30, 2024 | 14.43 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 4.79 Mn |
| Mar 31, 2024 | -658,794.00 |
| Mar 31, 2024 | -658,794.00 |
| Dec 31, 2023 | -185,888.00 |
| Dec 31, 2023 | -185,888.00 |